Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for intravenous (IV) administration.
Providing flexible dosing options, it is also licensed for intramuscular (IM) administration in cattle.
It is a popular premedication for use in cattle sedation and brief surgical procedures.
It has zero milk withdrawal and short one-day meat withdrawal.
Sedation occurs in cattle within two minutes IV and 5 to 10 minutes IM.
Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s extensive anaesthesia and sedation range.
Nerfasin vet also contains xylazine and is licensed for IV administration for sedation and premedication prior to general anaesthesia in horses and cattle.
Alana McGlade, national sales manager at Dechra, comments: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal.
“Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.
For further information on Sedaxylan 20mg/ml or Nerfasin vet 100mg/ml, please contact your local Dechra territory sales manager or visit their website.
